JPH08511016A - アミノアルキルグアニジンの製造法 - Google Patents
アミノアルキルグアニジンの製造法Info
- Publication number
- JPH08511016A JPH08511016A JP7501652A JP50165295A JPH08511016A JP H08511016 A JPH08511016 A JP H08511016A JP 7501652 A JP7501652 A JP 7501652A JP 50165295 A JP50165295 A JP 50165295A JP H08511016 A JPH08511016 A JP H08511016A
- Authority
- JP
- Japan
- Prior art keywords
- group
- benzyl
- reaction
- branched
- hours
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 8
- 238000000034 method Methods 0.000 claims abstract description 43
- 150000004985 diamines Chemical class 0.000 claims abstract description 14
- 239000003153 chemical reaction reagent Substances 0.000 claims abstract description 13
- 150000001875 compounds Chemical class 0.000 claims abstract description 11
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 claims description 104
- 238000006243 chemical reaction Methods 0.000 claims description 23
- -1 alkyl nitrile Chemical class 0.000 claims description 21
- 239000011541 reaction mixture Substances 0.000 claims description 20
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 claims description 18
- 125000000217 alkyl group Chemical group 0.000 claims description 17
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 claims description 15
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims description 15
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 14
- 239000002904 solvent Substances 0.000 claims description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims description 9
- 239000000376 reactant Substances 0.000 claims description 9
- IMNFDUFMRHMDMM-UHFFFAOYSA-N N-Heptane Chemical compound CCCCCCC IMNFDUFMRHMDMM-UHFFFAOYSA-N 0.000 claims description 8
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 claims description 8
- 239000008096 xylene Substances 0.000 claims description 8
- 150000003839 salts Chemical class 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 claims description 5
- ZRALSGWEFCBTJO-UHFFFAOYSA-N anhydrous guanidine Natural products NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 claims description 5
- 125000003710 aryl alkyl group Chemical group 0.000 claims description 5
- 239000004215 Carbon black (E152) Substances 0.000 claims description 4
- 229930195733 hydrocarbon Natural products 0.000 claims description 4
- 150000002430 hydrocarbons Chemical group 0.000 claims description 4
- 238000001556 precipitation Methods 0.000 claims description 4
- 125000003226 pyrazolyl group Chemical group 0.000 claims description 4
- 125000000999 tert-butyl group Chemical group [H]C([H])([H])C(*)(C([H])([H])[H])C([H])([H])[H] 0.000 claims description 4
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 claims description 3
- 150000004996 alkyl benzenes Chemical class 0.000 claims description 3
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 claims description 3
- IMLCWHLPMKBUSP-UHFFFAOYSA-N tert-butyl n-[n'-(3-aminopropyl)carbamimidoyl]carbamate Chemical compound CC(C)(C)OC(=O)NC(=N)NCCCN IMLCWHLPMKBUSP-UHFFFAOYSA-N 0.000 claims description 3
- 125000006539 C12 alkyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 2
- XDTMQSROBMDMFD-UHFFFAOYSA-N Cyclohexane Chemical compound C1CCCCC1 XDTMQSROBMDMFD-UHFFFAOYSA-N 0.000 claims description 2
- 239000002253 acid Substances 0.000 claims description 2
- 125000002015 acyclic group Chemical group 0.000 claims description 2
- 150000004945 aromatic hydrocarbons Chemical class 0.000 claims description 2
- RMFQGQYZMYQGGW-UHFFFAOYSA-N benzyl n-[n'-(2-aminoethyl)carbamimidoyl]carbamate Chemical compound NCCNC(=N)NC(=O)OCC1=CC=CC=C1 RMFQGQYZMYQGGW-UHFFFAOYSA-N 0.000 claims description 2
- UIUCNCJSSLVZLY-UHFFFAOYSA-N benzyl n-[n'-(8-aminooctyl)carbamimidoyl]carbamate Chemical compound NCCCCCCCCNC(=N)NC(=O)OCC1=CC=CC=C1 UIUCNCJSSLVZLY-UHFFFAOYSA-N 0.000 claims description 2
- 125000004122 cyclic group Chemical group 0.000 claims description 2
- 125000004400 (C1-C12) alkyl group Chemical group 0.000 claims 2
- NLFBCYMMUAKCPC-KQQUZDAGSA-N ethyl (e)-3-[3-amino-2-cyano-1-[(e)-3-ethoxy-3-oxoprop-1-enyl]sulfanyl-3-oxoprop-1-enyl]sulfanylprop-2-enoate Chemical compound CCOC(=O)\C=C\SC(=C(C#N)C(N)=O)S\C=C\C(=O)OCC NLFBCYMMUAKCPC-KQQUZDAGSA-N 0.000 claims 2
- ZFQZEWXWVVMRFB-UHFFFAOYSA-N benzyl N-[amino-(3,5-dimethyl-1H-pyrazol-4-yl)methylidene]carbamate Chemical compound CC1=NNC(C)=C1C(=N)NC(=O)OCC1=CC=CC=C1 ZFQZEWXWVVMRFB-UHFFFAOYSA-N 0.000 claims 1
- AAMQEHJYBWSPBR-UHFFFAOYSA-N benzyl n-[n'-(12-aminododecyl)carbamimidoyl]carbamate Chemical compound NCCCCCCCCCCCCNC(=N)NC(=O)OCC1=CC=CC=C1 AAMQEHJYBWSPBR-UHFFFAOYSA-N 0.000 claims 1
- NJNOSOZIVRRKCT-UHFFFAOYSA-N benzyl n-[n'-(5-aminopentyl)carbamimidoyl]carbamate Chemical compound NCCCCCNC(=N)NC(=O)OCC1=CC=CC=C1 NJNOSOZIVRRKCT-UHFFFAOYSA-N 0.000 claims 1
- XJXVUQKEFCGFNA-UHFFFAOYSA-N tert-butyl N-[amino-(3,5-dimethyl-1H-pyrazol-4-yl)methylidene]carbamate Chemical compound CC1=NNC(C)=C1C(=N)NC(=O)OC(C)(C)C XJXVUQKEFCGFNA-UHFFFAOYSA-N 0.000 claims 1
- 125000002795 guanidino group Chemical group C(N)(=N)N* 0.000 abstract description 6
- 125000003277 amino group Chemical group 0.000 abstract description 5
- 125000004453 alkoxycarbonyl group Chemical group 0.000 abstract description 3
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000000047 product Substances 0.000 description 22
- XFNJVJPLKCPIBV-UHFFFAOYSA-N trimethylenediamine Chemical compound NCCCN XFNJVJPLKCPIBV-UHFFFAOYSA-N 0.000 description 16
- 238000001914 filtration Methods 0.000 description 15
- 125000000956 methoxy group Chemical group [H]C([H])([H])O* 0.000 description 15
- HEDRZPFGACZZDS-MICDWDOJSA-N Trichloro(2H)methane Chemical compound [2H]C(Cl)(Cl)Cl HEDRZPFGACZZDS-MICDWDOJSA-N 0.000 description 14
- 239000013078 crystal Substances 0.000 description 14
- 239000000203 mixture Substances 0.000 description 14
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 12
- 125000006239 protecting group Chemical group 0.000 description 12
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 9
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000003786 synthesis reaction Methods 0.000 description 9
- 230000015572 biosynthetic process Effects 0.000 description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 8
- 108090000765 processed proteins & peptides Proteins 0.000 description 7
- 239000004475 Arginine Substances 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- QYPPJABKJHAVHS-UHFFFAOYSA-N agmatine Chemical compound NCCCCNC(N)=N QYPPJABKJHAVHS-UHFFFAOYSA-N 0.000 description 6
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 6
- IXDJJDXZZPHUAY-UHFFFAOYSA-N benzyl n-[n'-(3-aminopropyl)carbamimidoyl]carbamate Chemical compound NCCCNC(=N)NC(=O)OCC1=CC=CC=C1 IXDJJDXZZPHUAY-UHFFFAOYSA-N 0.000 description 6
- 238000003756 stirring Methods 0.000 description 6
- XXJGBENTLXFVFI-UHFFFAOYSA-N 1-amino-methylene Chemical compound N[CH2] XXJGBENTLXFVFI-UHFFFAOYSA-N 0.000 description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 5
- 125000001584 benzyloxycarbonyl group Chemical group C(=O)(OCC1=CC=CC=C1)* 0.000 description 5
- 229960004592 isopropanol Drugs 0.000 description 5
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 5
- 244000007835 Cyamopsis tetragonoloba Species 0.000 description 4
- 150000001412 amines Chemical class 0.000 description 4
- MLYVUDZUFYUWHE-UHFFFAOYSA-N benzyl (nz)-n-[amino(methoxy)methylidene]carbamate Chemical compound COC(N)=NC(=O)OCC1=CC=CC=C1 MLYVUDZUFYUWHE-UHFFFAOYSA-N 0.000 description 4
- 238000002425 crystallisation Methods 0.000 description 4
- 230000008025 crystallization Effects 0.000 description 4
- KIDHWZJUCRJVML-UHFFFAOYSA-N putrescine Chemical compound NCCCCN KIDHWZJUCRJVML-UHFFFAOYSA-N 0.000 description 4
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- PIICEJLVQHRZGT-UHFFFAOYSA-N Ethylenediamine Chemical compound NCCN PIICEJLVQHRZGT-UHFFFAOYSA-N 0.000 description 3
- UYTPUPDQBNUYGX-UHFFFAOYSA-N Guanine Natural products O=C1NC(N)=NC2=C1N=CN2 UYTPUPDQBNUYGX-UHFFFAOYSA-N 0.000 description 3
- 229910002651 NO3 Inorganic materials 0.000 description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 3
- WGYKZJWCGVVSQN-UHFFFAOYSA-N propylamine Chemical group CCCN WGYKZJWCGVVSQN-UHFFFAOYSA-N 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 125000004042 4-aminobutyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])N([H])[H] 0.000 description 2
- PNKUSGQVOMIXLU-UHFFFAOYSA-N Formamidine Chemical compound NC=N PNKUSGQVOMIXLU-UHFFFAOYSA-N 0.000 description 2
- ATUOYWHBWRKTHZ-UHFFFAOYSA-N Propane Chemical compound CCC ATUOYWHBWRKTHZ-UHFFFAOYSA-N 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-N Sulfuric acid Chemical compound OS(O)(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-N 0.000 description 2
- 150000001483 arginine derivatives Chemical class 0.000 description 2
- DCQAIGHVRXHOSL-UHFFFAOYSA-N benzyl [carbamoyl(ethyl)amino] carbonate Chemical compound C(C1=CC=CC=C1)OC(=O)ON(C(O)=N)CC DCQAIGHVRXHOSL-UHFFFAOYSA-N 0.000 description 2
- 235000008429 bread Nutrition 0.000 description 2
- VHRGRCVQAFMJIZ-UHFFFAOYSA-N cadaverine Chemical compound NCCCCCN VHRGRCVQAFMJIZ-UHFFFAOYSA-N 0.000 description 2
- 125000004432 carbon atom Chemical group C* 0.000 description 2
- 239000012043 crude product Substances 0.000 description 2
- QFTYSVGGYOXFRQ-UHFFFAOYSA-N dodecane-1,12-diamine Chemical compound NCCCCCCCCCCCCN QFTYSVGGYOXFRQ-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910052739 hydrogen Inorganic materials 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 102000004196 processed proteins & peptides Human genes 0.000 description 2
- ZNZJJSYHZBXQSM-UHFFFAOYSA-N propane-2,2-diamine Chemical compound CC(C)(N)N ZNZJJSYHZBXQSM-UHFFFAOYSA-N 0.000 description 2
- 230000035484 reaction time Effects 0.000 description 2
- 125000002088 tosyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1C([H])([H])[H])S(*)(=O)=O 0.000 description 2
- PWGJDPKCLMLPJW-UHFFFAOYSA-N 1,8-diaminooctane Chemical compound NCCCCCCCCN PWGJDPKCLMLPJW-UHFFFAOYSA-N 0.000 description 1
- MLRVZFYXUZQSRU-UHFFFAOYSA-N 1-chlorohexane Chemical compound CCCCCCCl MLRVZFYXUZQSRU-UHFFFAOYSA-N 0.000 description 1
- WRGLZNWEJGKYHH-UHFFFAOYSA-N 2-(3-aminopropyl)guanidine Chemical compound NCCCNC(N)=N WRGLZNWEJGKYHH-UHFFFAOYSA-N 0.000 description 1
- 125000000022 2-aminoethyl group Chemical group [H]C([*])([H])C([H])([H])N([H])[H] 0.000 description 1
- QVNVGTVAPQGSOF-UHFFFAOYSA-L 3-[4-(9,9-dimethyl-3-aza-9-azoniabicyclo[3.3.1]nonan-3-yl)butyl]-9,9-dimethyl-3-aza-9-azoniabicyclo[3.3.1]nonane;diiodide Chemical compound [I-].[I-].C1C([N+]2(C)C)CCCC2CN1CCCCN(C1)CC2CCCC1[N+]2(C)C QVNVGTVAPQGSOF-UHFFFAOYSA-L 0.000 description 1
- ZCYVEMRRCGMTRW-UHFFFAOYSA-N 7553-56-2 Chemical compound [I] ZCYVEMRRCGMTRW-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- OPFTUNCRGUEPRZ-QLFBSQMISA-N Cyclohexane Natural products CC(=C)[C@@H]1CC[C@@](C)(C=C)[C@H](C(C)=C)C1 OPFTUNCRGUEPRZ-QLFBSQMISA-N 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- NVNLLIYOARQCIX-MSHCCFNRSA-N Nisin Chemical compound N1C(=O)[C@@H](CC(C)C)NC(=O)C(=C)NC(=O)[C@@H]([C@H](C)CC)NC(=O)[C@@H](NC(=O)C(=C/C)/NC(=O)[C@H](N)[C@H](C)CC)CSC[C@@H]1C(=O)N[C@@H]1C(=O)N2CCC[C@@H]2C(=O)NCC(=O)N[C@@H](C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(NCC(=O)N[C@H](C)C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCSC)C(=O)NCC(=O)N[C@H](CS[C@@H]2C)C(=O)N[C@H](CC(N)=O)C(=O)N[C@H](CCSC)C(=O)N[C@H](CCCCN)C(=O)N[C@@H]2C(N[C@H](C)C(=O)N[C@@H]3C(=O)N[C@@H](C(N[C@H](CC=4NC=NC=4)C(=O)N[C@H](CS[C@@H]3C)C(=O)N[C@H](CO)C(=O)N[C@H]([C@H](C)CC)C(=O)N[C@H](CC=3NC=NC=3)C(=O)N[C@H](C(C)C)C(=O)NC(=C)C(=O)N[C@H](CCCCN)C(O)=O)=O)CS[C@@H]2C)=O)=O)CS[C@@H]1C NVNLLIYOARQCIX-MSHCCFNRSA-N 0.000 description 1
- 108010053775 Nisin Proteins 0.000 description 1
- 239000005700 Putrescine Substances 0.000 description 1
- 229910006069 SO3H Inorganic materials 0.000 description 1
- BLRPTPMANUNPDV-UHFFFAOYSA-N Silane Chemical compound [SiH4] BLRPTPMANUNPDV-UHFFFAOYSA-N 0.000 description 1
- 230000010933 acylation Effects 0.000 description 1
- 238000005917 acylation reaction Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 125000003545 alkoxy group Chemical group 0.000 description 1
- 150000001414 amino alcohols Chemical class 0.000 description 1
- 125000004103 aminoalkyl group Chemical group 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 125000000637 arginyl group Chemical group N[C@@H](CCCNC(N)=N)C(=O)* 0.000 description 1
- KKYALIQGNUBCNB-UHFFFAOYSA-N benzyl (methylcarbamoylamino) carbonate Chemical compound C(C1=CC=CC=C1)OC(=O)ON=C(NC)O KKYALIQGNUBCNB-UHFFFAOYSA-N 0.000 description 1
- ZHNUXJSPYNQQHV-UHFFFAOYSA-N benzyl (nz)-n-[amino(methylsulfanyl)methylidene]carbamate Chemical compound CSC(=N)NC(=O)OCC1=CC=CC=C1 ZHNUXJSPYNQQHV-UHFFFAOYSA-N 0.000 description 1
- HSDAJNMJOMSNEV-UHFFFAOYSA-N benzyl chloroformate Chemical compound ClC(=O)OCC1=CC=CC=C1 HSDAJNMJOMSNEV-UHFFFAOYSA-N 0.000 description 1
- DLEXEXIDPYXCNP-UHFFFAOYSA-N benzyl n-[n'-(4-aminobutyl)carbamimidoyl]carbamate Chemical compound NCCCCNC(=N)NC(=O)OCC1=CC=CC=C1 DLEXEXIDPYXCNP-UHFFFAOYSA-N 0.000 description 1
- 239000001273 butane Substances 0.000 description 1
- GHWVXCQZPNWFRO-UHFFFAOYSA-N butane-2,3-diamine Chemical compound CC(N)C(C)N GHWVXCQZPNWFRO-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 125000002915 carbonyl group Chemical group [*:2]C([*:1])=O 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 238000010596 desymmetrization reaction Methods 0.000 description 1
- ODCCJTMPMUFERV-UHFFFAOYSA-N ditert-butyl carbonate Chemical compound CC(C)(C)OC(=O)OC(C)(C)C ODCCJTMPMUFERV-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000012458 free base Substances 0.000 description 1
- 150000002357 guanidines Chemical class 0.000 description 1
- ZRALSGWEFCBTJO-UHFFFAOYSA-O guanidinium Chemical compound NC(N)=[NH2+] ZRALSGWEFCBTJO-UHFFFAOYSA-O 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 229910052740 iodine Inorganic materials 0.000 description 1
- 239000011630 iodine Substances 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- GSYSFVSGPABNNL-UHFFFAOYSA-N methyl 2-dimethoxyphosphoryl-2-(phenylmethoxycarbonylamino)acetate Chemical group COC(=O)C(P(=O)(OC)OC)NC(=O)OCC1=CC=CC=C1 GSYSFVSGPABNNL-UHFFFAOYSA-N 0.000 description 1
- 125000006217 methyl sulfide group Chemical group [H]C([H])([H])S* 0.000 description 1
- UIUXUFNYAYAMOE-UHFFFAOYSA-N methylsilane Chemical compound [SiH3]C UIUXUFNYAYAMOE-UHFFFAOYSA-N 0.000 description 1
- 230000003278 mimic effect Effects 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- OFBQJSOFQDEBGM-UHFFFAOYSA-N n-pentane Natural products CCCCC OFBQJSOFQDEBGM-UHFFFAOYSA-N 0.000 description 1
- CMWTZPSULFXXJA-VIFPVBQESA-N naproxen Chemical group C1=C([C@H](C)C(O)=O)C=CC2=CC(OC)=CC=C21 CMWTZPSULFXXJA-VIFPVBQESA-N 0.000 description 1
- 239000004309 nisin Substances 0.000 description 1
- 235000010297 nisin Nutrition 0.000 description 1
- 239000012454 non-polar solvent Substances 0.000 description 1
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 1
- 239000002798 polar solvent Substances 0.000 description 1
- 239000001294 propane Substances 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 125000004353 pyrazol-1-yl group Chemical group [H]C1=NN(*)C([H])=C1[H] 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- 238000007086 side reaction Methods 0.000 description 1
- 229910000077 silane Inorganic materials 0.000 description 1
- 239000000377 silicon dioxide Substances 0.000 description 1
- 239000011877 solvent mixture Substances 0.000 description 1
- 125000000020 sulfo group Chemical group O=S(=O)([*])O[H] 0.000 description 1
- UMGDCJDMYOKAJW-UHFFFAOYSA-N thiourea Chemical compound NC(N)=S UMGDCJDMYOKAJW-UHFFFAOYSA-N 0.000 description 1
- 125000003944 tolyl group Chemical group 0.000 description 1
- 238000001665 trituration Methods 0.000 description 1
- 238000005292 vacuum distillation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C277/00—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C277/08—Preparation of guanidine or its derivatives, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups of substituted guanidines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C279/00—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups
- C07C279/20—Derivatives of guanidine, i.e. compounds containing the group, the singly-bound nitrogen atoms not being part of nitro or nitroso groups containing any of the groups, X being a hetero atom, Y being any atom, e.g. acylguanidines
- C07C279/24—Y being a hetero atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Compositions Of Macromolecular Compounds (AREA)
- Treatments For Attaching Organic Compounds To Fibrous Goods (AREA)
Abstract
Description
Claims (1)
- 【特許請求の範囲】 1.一般式I NH2−CnH2n−NH2 (I) のジアミンを一般式II ROC(O)−N=C(L)−NH2 (II) のグアニル化試薬、その互変異性体またはその塩と反応させることを特徴とす る、一般式III H2N−CnH2n−NH−C(=NH)−NH−C(O)−O−R (III) の保護されたω−アミノアルキルグアニジン、その互変異性体またはその塩の 製造法〔上記式中、−CnH2n−は直鎖または分枝アルキル基であり、nは2〜18 の整数であり、Rは、直鎖または分枝C1〜C12−アルキル基、例えば低級アルキ ル基およびアラルキル基、例えばベンジルまたは置換されたベンジルからなる群 から選ばれ、そしてLはR2O、R2S、ピラゾリルおよび置換されたピラゾリル(こ こでR2は低級アルキル基である)の基からなる群より選ばれる残基である〕。 2.−CnH2n−は、nが2〜12の直鎖アルキル基であることを特徴とする、請求 項1の方法。 3.−CnH2n−は、nが2〜5、8または12の直鎖アルキル基であり、Rはt− ブチルまたはベンジル基であることを特徴とする、請求項1の方法。 4.nは3であり、Rはベンジル基であることを特徴とする、請求項3の方法。 5.前記反応を溶媒なしで、または溶媒の存在下で実施し、好ましくは溶媒なし で、または溶媒を使用する場合は、好ましくは芳香 族炭化水素、例えばアルキルベンゼン、そしてさらに特定するとトルエンまたは キシレン;直鎖または分枝、環式または非環式、例えばヘキサン、ヘプタンまた はシクロヘキサンである炭化水素;アルキルニトリル、例えばアセトニトリル; アルコール、例えばイソプロパノール;または水であることを特徴とする、請求 項1の方法。 6.前記反応をほぼ少なくとも化学量論量のジアミン反応物、好ましくはグアニ ル化反応物に対して1〜10モル当量用いて実施することを特徴とする、請求項1 の方法。 7.ジアミン反応物をグアニル化反応物に対して1.5〜6モル当量、好ましくは 2〜4モル当量で使用することを特徴とする、請求項6の方法。 8.前記反応を約20〜80℃、好ましくは約40〜60℃の反応温度で実施することを 特徴とする、請求項1の方法。 9.化合物IIIを結晶生成物の形態で反応混合物から沈殿により単離することを 特徴とする、請求項1の方法。 10.化合物IIIを酸、好ましくは塩酸を用いて沈殿させることを特徴とする、請 求項9の方法。 11.一般式III H2N−CnH2n−NH−C(=NH)−NH−C(O)−O−R (III) (式中、-CnH2n-は直鎖または分枝アルキル基であり、nは2〜18の整数であ り、そしてRは直鎖または分枝C1〜C12アルキル基、例えば低級アルキルおよび アラルキル基、例えばベンジルまたは置換されたベンジルからなる群から選ばれ るが、但しn=3の時はRはベンジルではなく、そしてn=4の時は、Rはt− ブチル でもベンジルでもない)の化合物、その互変異性体またはその塩。 12.−CnH2n−が、nが2〜12である直鎖アルキル基であることを特徴とする、 請求項11の化合物。 13.−CnH2n−が、nが2〜5、8または12である直鎖アルキル基であり、そし てRがt−ブチルまたはベンジル基であることを特徴とする、請求項11の化合物 。 14.N−(3−アミノプロピル)−N′−t−ブトキシカルボニルグアニジン、 N−(2−アミノエチル)−N′−ベンジルオキシカルボニルグアニジン、N− (5−アミノペンチル)−N′−ベンジルオキシカルボニルグアニジン、N−( 8−アミノオクチル)−N′−ベンジルオキシカルボニルグアニジン、N−(12 −アミノドデシル)−N′−ベンジルオキシカルボニルグアニジン。 15.N−ベンジルオキシカルボニル−1−[3,5−ジメチルピラゾリル]ホルム アミジンおよびt−ブトキシカルボニル−1−(3,5−ジメチルピラゾリル)ホ ルムアミジン。 16.請求項1〜9の一つに定義された方法によって製造される、一般式III H2N−CnH2n−NH−C(=NH)−NH−C(O)−O−R (III) (式中、-CnH2n-は直鎖または分枝アルキル基であり、nは2〜18の整数であ り、そしてRは直鎖または分枝C1〜C12アルキル基、例えば低級アルキルおよび アラルキル基、例えばベンジルまたは置換されたベンジルからなる群から選ばれ る)の生成物、その互変異性体またはその塩。
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| SE9301912-3 | 1993-06-03 | ||
| SE19939301912A SE9301912D0 (sv) | 1993-06-03 | 1993-06-03 | Process for the production of aminoalkylguandines |
| PCT/SE1994/000517 WO1994029269A1 (en) | 1993-06-03 | 1994-06-01 | Process for the production of aminoalkylguanidines |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPH08511016A true JPH08511016A (ja) | 1996-11-19 |
| JP3662925B2 JP3662925B2 (ja) | 2005-06-22 |
Family
ID=20390162
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP50165295A Expired - Fee Related JP3662925B2 (ja) | 1993-06-03 | 1994-06-01 | アミノアルキルグアニジンの製造法 |
Country Status (27)
| Country | Link |
|---|---|
| US (1) | US5659071A (ja) |
| EP (1) | EP0701550B1 (ja) |
| JP (1) | JP3662925B2 (ja) |
| CN (1) | CN1124956A (ja) |
| AT (1) | ATE178316T1 (ja) |
| AU (1) | AU674970B2 (ja) |
| BR (1) | BR9406713A (ja) |
| CA (1) | CA2162920C (ja) |
| CZ (1) | CZ320095A3 (ja) |
| DE (1) | DE69417554T2 (ja) |
| DK (1) | DK0701550T3 (ja) |
| EE (1) | EE9400348A (ja) |
| ES (1) | ES2131688T3 (ja) |
| FI (1) | FI120093B (ja) |
| GR (1) | GR3030501T3 (ja) |
| HR (1) | HRP940317A2 (ja) |
| HU (1) | HUT74293A (ja) |
| IL (1) | IL109683A0 (ja) |
| IS (1) | IS4165A (ja) |
| LT (1) | LT3309B (ja) |
| NO (1) | NO305514B1 (ja) |
| NZ (1) | NZ267192A (ja) |
| PL (1) | PL311760A1 (ja) |
| SE (1) | SE9301912D0 (ja) |
| SK (1) | SK151895A3 (ja) |
| WO (1) | WO1994029269A1 (ja) |
| YU (1) | YU33594A (ja) |
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013151484A (ja) * | 2011-12-28 | 2013-08-08 | Towa Yakuhin Kk | イソウレア化合物を用いるエピナスチンの製造方法 |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5610308A (en) * | 1995-05-18 | 1997-03-11 | Bristol-Myers Squibb Company | Process for preparing intermediates for thrombin inhibitors |
| JP2000502078A (ja) * | 1995-12-09 | 2000-02-22 | ベーリンガー マンハイム ゲゼルシャフト ミット ベシュレンクテル ハフツング | 擬似アルギニン特性を有する3―アミノエチル―n―アミジノ―2,5―ジヒドロピロール誘導体 |
| US7129233B2 (en) | 2000-12-01 | 2006-10-31 | Astrazeneca Ab | Mandelic acid derivatives and their use as thrombin inhibitors |
| AR035216A1 (es) * | 2000-12-01 | 2004-05-05 | Astrazeneca Ab | Derivados de acido mandelico ,derivados farmaceuticamente aceptables, uso de estos derivados para la fabricacion de medicamentos, metodos de tratamiento ,procesos para la preparacion de estos derivados, y compuestos intermediarios |
| FR2822463B1 (fr) | 2001-03-21 | 2004-07-30 | Lipha | Derives bicycliques de guanidines et leurs applications en therapeutique |
| AR034517A1 (es) * | 2001-06-21 | 2004-02-25 | Astrazeneca Ab | Formulacion farmaceutica |
| SE0201661D0 (sv) * | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | New salts |
| SE0201659D0 (sv) | 2002-05-31 | 2002-05-31 | Astrazeneca Ab | Modified release pharmaceutical formulation |
| US7781424B2 (en) * | 2003-05-27 | 2010-08-24 | Astrazeneca Ab | Modified release pharmaceutical formulation |
| US7524354B2 (en) * | 2005-07-07 | 2009-04-28 | Research Foundation Of State University Of New York | Controlled synthesis of highly monodispersed gold nanoparticles |
| WO2008008872A2 (en) | 2006-07-14 | 2008-01-17 | Wisconsin Alumni Research Foundation | Adsorptive membranes for trapping viruses |
| TW200827336A (en) * | 2006-12-06 | 2008-07-01 | Astrazeneca Ab | New crystalline forms |
| US20090061000A1 (en) * | 2007-08-31 | 2009-03-05 | Astrazeneca Ab | Pharmaceutical formulation use 030 |
| WO2015146882A1 (ja) * | 2014-03-28 | 2015-10-01 | 株式会社カネカ | トリ-カルボベンゾキシ-アルギニンの製造方法 |
| US12098118B2 (en) | 2018-11-07 | 2024-09-24 | Regents Of The University Of Minnesota | Analgesic and anti-addictive compositions for treatment of chronic pain and opioid addiction |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE463576C (de) * | 1924-08-06 | 1928-07-31 | Schering Kahlbaum Akt Ges | Verfahren zur Darstellung von Aminoguanidinen oder deren Salzen |
| FR2294699A1 (fr) * | 1974-12-19 | 1976-07-16 | Bottu | Nouveaux derives du pyrazole et compositions pharmaceutiques les renfermant |
| HU178398B (en) | 1979-06-12 | 1982-04-28 | Gyogyszerkutato Intezet | Process for producing new agmatine derivatives of activity against haemagglutination |
| US4387049A (en) | 1982-02-22 | 1983-06-07 | Smithkline Beckman Corporation | Adamantyl containing peptides |
| DE3222342A1 (de) * | 1982-06-14 | 1983-12-15 | Hoechst Ag, 6230 Frankfurt | 6-aryl-1,2,4-triazolo (4,3-b) pyridazin-3-carbaminate, ihre herstellung und sie enthaltende arzneimittel |
| US4914189A (en) * | 1987-02-05 | 1990-04-03 | The Adminstrators Of The Tulane Educational Fund | Synthetic GHRH analogs |
| ES2086127T5 (es) * | 1991-07-03 | 1999-11-01 | Du Pont | Composiciones azeotropicas o semejantes a azeotropos de pentafluoroetano y propano o isobutano. |
| US5498724A (en) * | 1994-06-28 | 1996-03-12 | Aktiebolaget Astra | Pyrazoleamidine compounds |
-
1993
- 1993-06-03 SE SE19939301912A patent/SE9301912D0/xx unknown
-
1994
- 1994-05-11 IS IS4165A patent/IS4165A/is unknown
- 1994-05-18 LT LTIP1940A patent/LT3309B/lt not_active IP Right Cessation
- 1994-05-19 IL IL10968394A patent/IL109683A0/xx unknown
- 1994-05-23 HR HR9301912-3A patent/HRP940317A2/xx not_active Application Discontinuation
- 1994-06-01 AT AT94917867T patent/ATE178316T1/de active
- 1994-06-01 BR BR9406713A patent/BR9406713A/pt not_active Application Discontinuation
- 1994-06-01 WO PCT/SE1994/000517 patent/WO1994029269A1/en not_active Ceased
- 1994-06-01 DE DE69417554T patent/DE69417554T2/de not_active Expired - Lifetime
- 1994-06-01 CZ CZ953200A patent/CZ320095A3/cs unknown
- 1994-06-01 CA CA002162920A patent/CA2162920C/en not_active Expired - Fee Related
- 1994-06-01 SK SK1518-95A patent/SK151895A3/sk unknown
- 1994-06-01 DK DK94917867T patent/DK0701550T3/da active
- 1994-06-01 HU HU9503444A patent/HUT74293A/hu unknown
- 1994-06-01 NZ NZ267192A patent/NZ267192A/en not_active IP Right Cessation
- 1994-06-01 AU AU69404/94A patent/AU674970B2/en not_active Ceased
- 1994-06-01 US US08/244,924 patent/US5659071A/en not_active Expired - Lifetime
- 1994-06-01 JP JP50165295A patent/JP3662925B2/ja not_active Expired - Fee Related
- 1994-06-01 CN CN94192325A patent/CN1124956A/zh active Pending
- 1994-06-01 PL PL94311760A patent/PL311760A1/xx unknown
- 1994-06-01 ES ES94917867T patent/ES2131688T3/es not_active Expired - Lifetime
- 1994-06-01 EP EP94917867A patent/EP0701550B1/en not_active Expired - Lifetime
- 1994-06-03 YU YU33594A patent/YU33594A/sh unknown
- 1994-11-17 EE EE9400348A patent/EE9400348A/xx unknown
-
1995
- 1995-11-28 NO NO954835A patent/NO305514B1/no not_active IP Right Cessation
- 1995-12-01 FI FI955800A patent/FI120093B/fi not_active IP Right Cessation
-
1999
- 1999-06-10 GR GR990401576T patent/GR3030501T3/el unknown
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2013151484A (ja) * | 2011-12-28 | 2013-08-08 | Towa Yakuhin Kk | イソウレア化合物を用いるエピナスチンの製造方法 |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JPH08511016A (ja) | アミノアルキルグアニジンの製造法 | |
| UA80298C2 (en) | 1h-1,2,4-triazole-3-carboxamide derivatives as cannabinoid-cb1 receptor ligands | |
| HUP0000667A2 (en) | Antithrombotic organic nitrates | |
| CZ187895A3 (en) | Amino acid derivatives, medicaments containing said derivatives and process for preparing thereof | |
| US5498724A (en) | Pyrazoleamidine compounds | |
| JPS61500549A (ja) | 非イオン性放射線写真コントラスト媒体のための新合成方法 | |
| HUT70048A (en) | Neurotensine-receptor-active 1-naphtyl-pyrazol-3-carboxamides process for producing them and pharmaceutical compositions containing them as active components | |
| AU2018321152B2 (en) | Novel cystobactamide derivatives | |
| AU617121B2 (en) | Substituted guanidines containing a tetrazolyl moiety and their use as high potency sweetening agents | |
| JPH11504024A (ja) | 薬学的に活性な化合物の中間体としてのヒダントイン誘導体 | |
| CN107108476A (zh) | 丙氨酸n‑乙酸前体的晶体、其制备方法及其应用 | |
| US4150146A (en) | Process for the preparation of unsymmetrically 1,3-disubstituted nitroso ureas | |
| US2543345A (en) | Method of preparing glutamic acid amides | |
| EP0684227B1 (en) | Process for the manufacture of guanidines | |
| WO2007091390A1 (ja) | ニトロイソウレア誘導体の改良された製造方法 | |
| US6258976B1 (en) | Process for the preparation of polyamines and polyamine derivatives | |
| AU717834B2 (en) | Preparation of optically active (S)-(-) and (R)-(+)- deoxyspergualin and novel intermediates thereof | |
| RU2250897C1 (ru) | Способ получения адамантилсодержащих n-имидоилированных эфиров аминокарбоновых кислот | |
| HU190527B (en) | Process for preparing thiazole derivatives | |
| US4209624A (en) | Process for preparing substituted bis(amidinoureas) | |
| CN110128344B (zh) | 一种n-取代-3,5-二硝基吡唑类化合物及其制备方法 | |
| Koziara et al. | A New Route to Monoalkylhydrazines | |
| FI83637B (fi) | Syraadditionssalter av alkyl-1-/ (2-fenoxietyl)amino/propylidenhydrazinkarboxylat och foerfarande foer deras framstaellning. | |
| CN104379556B (zh) | 使用氨基酸n-羧酸酐合成二酰胺基胶凝剂的方法 | |
| JP4739695B2 (ja) | 5−アミノ―1―置換―1,2,4―トリアゾールの製造方法、及び該製造方法で得られるトリアゾール誘導体 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20040401 |
|
| A602 | Written permission of extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A602 Effective date: 20040517 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20040713 |
|
| A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20041005 |
|
| A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20050201 |
|
| A911 | Transfer to examiner for re-examination before appeal (zenchi) |
Free format text: JAPANESE INTERMEDIATE CODE: A911 Effective date: 20050217 |
|
| TRDD | Decision of grant or rejection written | ||
| A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20050308 |
|
| A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20050325 |
|
| R150 | Certificate of patent or registration of utility model |
Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20080401 Year of fee payment: 3 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20090401 Year of fee payment: 4 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100401 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20100401 Year of fee payment: 5 |
|
| FPAY | Renewal fee payment (event date is renewal date of database) |
Free format text: PAYMENT UNTIL: 20110401 Year of fee payment: 6 |
|
| LAPS | Cancellation because of no payment of annual fees |